Phytochemicals Targeting Mitophagy to Treat Heart Diseases: Retrospective Insights and Prospective Directions
Authors:
- 6 February 2025
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 39 (3) , 1592-1614
Abstract
Mitophagy is a process by which cells selectively eliminate damaged or dysfunctional mitochondria through the autophagy–lysosome pathway, thereby maintaining mitochondrial quality and cellular homeostasis. This process is closely linked to the onset and progression of various heart diseases. Modern pharmacological research has demonstrated that phytochemicals can regulate mitochondrial homeostasis in cardiomyocytes through multiple mechanisms, influencing mitophagy and protecting cardiomyocytes, which in turn exerts anti‐cardiovascular effects. However, the underlying mechanisms of these effects are not yet fully understood. This study summarizes the pharmacological effects and molecular mechanisms of mitophagy in heart diseases, aiming to provide reference for the research and treatment of phytochemicals targeting mitophagy against heart diseases. The results indicated that phytochemicals (such as Berberine, Ginsenoside Rg1, Quercetin, Resveratrol, Baicalein, and so on) can exert preventive and therapeutic effects on heart diseases (such as cardiac toxicity or damage, myocardial ischemia/reperfusion injury, heart failure, heart aging, cardiac hypertrophy, cardiomyopathy, and so on.) via regulating the PINK1/Parkin and FUNDC1‐dependent mitophagy pathway. These compounds mainly exert their effects by regulating mitochondrial homeostasis, mitochondrial dynamics, mitochondrial oxidative stress, mitochondrial apoptosis, and mitochondrial energy metabolism. This study provides a reference that phytochemicals have effect on anti‐cardiovascular effects by regulating mitophagy. However, further in‐depth mechanistic and clinical research are needed in the future.Keywords
Funding Information
- National Natural Science Foundation of China (82304738)
This publication has 94 references indexed in Scilit:
- Deciphering the Power of Resveratrol in Mitophagy: From Molecular Mechanisms to Therapeutic ApplicationsPhytotherapy Research, 2025
- Phytochemicals targeting ferroptosis in cardiovascular diseases: Recent advances and therapeutic perspectivesPhytotherapy Research, 2024
- Quercetin inhibits necroptosis in cardiomyocytes after ischemia–reperfusion via DNA‐PKcs‐SIRT5‐orchestrated mitochondrial quality controlPhytotherapy Research, 2024
- Ginsenoside Rg1 Protects against Cardiac Remodeling in Heart Failure via SIRT1/PINK1/Parkin‐Mediated MitophagyChemistry & Biodiversity, 2023
- Irisin ameliorates age‐associated sarcopenia and metabolic dysfunctionJournal of Cachexia, Sarcopenia and Muscle, 2022
- Defective mitophagy in Alzheimer's diseaseAgeing Research Reviews, 2020
- Ginsenoside Rg1 protects H9c2 cells against nutritional stress‐induced injury via aldolase /AMPK/PINK1 signallingJournal of Cellular Biochemistry, 2019
- Dietary quercetin supplements: Assessment of online product informations and quantitation of quercetin in the products by high‐performance liquid chromatographyPhytotherapy Research, 2019
- FUN14 Domain‐Containing 1–Mediated Mitophagy Suppresses Hepatocarcinogenesis by Inhibition of Inflammasome Activation in MiceHepatology, 2019
- Dynamin‐related protein 1: A critical protein in the pathogenesis of neural system dysfunctions and neurodegenerative diseasesJournal of Cellular Physiology, 2018